Shi MQ - Search Results

1

Clinical investigation of efficacy of albumin bound paclitaxel plus platinum compounds as first-line chemotherapy for stage III/IV squamous non-small cell lung cancer.

Fang Y, Wang L, Xia GH, Shi MQ. Fang Y, et al. Among authors: shi mq. Asian Pac J Cancer Prev. 2014;15(17):7453-7. doi: 10.7314/apjcp.2014.15.17.7453. Asian Pac J Cancer Prev. 2014. PMID: 25227858 Free article.

2

[Prognostic significance of ERCC1 mRNA expression in patients with non-small cell lung cancer receiving platinum-based chemotherapy].

Qian XP, Liu BR, Shi MQ, Liu XZ, Hu WJ, Zou ZY, Wei J. Qian XP, et al. Among authors: shi mq. Zhonghua Zhong Liu Za Zhi. 2009 Jan;31(1):33-7. Zhonghua Zhong Liu Za Zhi. 2009. PMID: 19538866 Chinese.

3

Lack of influence of XRCC1 and XPD gene polymorphisms on outcome of platinum-based chemotherapy for advanced non small cell lung cancers.

Yao CY, Huang XE, Li C, Shen HB, Shi MQ, Feng JF, Pan LX, Tang JH. Yao CY, et al. Among authors: shi mq. Asian Pac J Cancer Prev. 2009;10(5):859-64. Asian Pac J Cancer Prev. 2009. PMID: 20104979 Free article.

4

Predictive value of ERCC1 and XPD polymorphism in patients with advanced non-small cell lung cancer receiving platinum-based chemotherapy: a systematic review and meta-analysis.

Wei SZ, Zhan P, Shi MQ, Shi Y, Qian Q, Yu LK, Song Y. Wei SZ, et al. Among authors: shi mq, shi y. Med Oncol. 2011 Mar;28(1):315-21. doi: 10.1007/s12032-010-9443-1. Epub 2010 Feb 9. Med Oncol. 2011. PMID: 20143185 Review.

5

Weekly paclitaxel/ docetaxel combined with a platinum in the treatment of advanced non-small cell lung cancer: a study on efficacy, safety and pre-medication.

Zhou JN, Huang XE, Ye Z, Li C, Zhang Q, Lin Y, Jiang W, Sunh WL, Shi MQ, Shu YQ. Zhou JN, et al. Among authors: shi mq. Asian Pac J Cancer Prev. 2009;10(6):1147-50. Asian Pac J Cancer Prev. 2009. PMID: 20192601 Free article.

6

Effect of EGFR-TKI retreatment following chemotherapy for advanced non-small cell lung cancer patients who underwent EGFR-TKI.

Xia GH, Zeng Y, Fang Y, Yu SR, Wang L, Shi MQ, Sun WL, Huang XE, Chen J, Feng JF. Xia GH, et al. Among authors: shi mq. Cancer Biol Med. 2014 Dec;11(4):270-6. doi: 10.7497/j.issn.2095-3941.2014.04.006. Cancer Biol Med. 2014. PMID: 25610713 Free PMC article.

7

A Randomized Multicenter Phase III Study of Single Administration of Mecapegfilgrastim (HHPG-19K), a Pegfilgrastim Biosimilar, for Prophylaxis of Chemotherapy-Induced Neutropenia in Patients With Advanced Non-Small-Cell Lung Cancer (NSCLC).

Zhou C, Huang Y, Wang D, An C, Zhou F, Li Y, Chen G, Wu C, He J, Wu G, Song X, Gao J, Liu W, Li B, Shi J, Huang C, Yu J, Feng J, Yue H, Shi M, Xia J. Zhou C, et al. Clin Lung Cancer. 2016 Mar;17(2):119-27. doi: 10.1016/j.cllc.2015.12.002. Epub 2015 Dec 17. Clin Lung Cancer. 2016. PMID: 26781346 Clinical Trial.

8

Phase I dose escalation and pharmacokinetic study on the nanoparticle formulation of polymeric micellar paclitaxel for injection in patients with advanced solid malignancies.

Shi M, Sun J, Zhou J, Yu H, Yu S, Xia G, Wang L, Teng Y, Liu G, Yu C, Feng J, Shen Y. Shi M, et al. Invest New Drugs. 2018 Apr;36(2):269-277. doi: 10.1007/s10637-017-0506-4. Epub 2017 Sep 4. Invest New Drugs. 2018. PMID: 28868573 Clinical Trial.

9

Phase III study of dulanermin (recombinant human tumor necrosis factor-related apoptosis-inducing ligand/Apo2 ligand) combined with vinorelbine and cisplatin in patients with advanced non-small-cell lung cancer.

Ouyang X, Shi M, Jie F, Bai Y, Shen P, Yu Z, Wang X, Huang C, Tao M, Wang Z, Xie C, Wu Q, Shu Y, Han B, Zhang F, Zhang Y, Hu C, Ma X, Liang Y, Wang A, Lu B, Shi Y, Chen J, Zhuang Z, Wang J, Huang J, Wang C, Bai C, Zhou X, Li Q, Chen F, Yu H, Feng J. Ouyang X, et al. Invest New Drugs. 2018 Apr;36(2):315-322. doi: 10.1007/s10637-017-0536-y. Epub 2017 Nov 14. Invest New Drugs. 2018. PMID: 29134432 Clinical Trial.

10

Clinical evaluation of carcinoembryonic and carbohydrate antigens as cancer biomarkers to monitor palliative chemotherapy in advanced stage gastric cancer.

Abbas M, Ahmed A, Khan GJ, Baig MMFA, Naveed M, Mikrani R, Cao T, Naeem S, Shi M, Dingding C. Abbas M, et al. Curr Probl Cancer. 2019 Feb;43(1):5-17. doi: 10.1016/j.currproblcancer.2018.08.003. Epub 2018 Aug 25. Curr Probl Cancer. 2019. PMID: 30172422

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

113 results

Search Page